当前位置:首页 > 文献互助 > 互助详情

First-in-class ACP3 high-affinity ligands isolated from DNA-encoded chemical libraries for the delivery of radionuclides against prostate cancer复制

用户qCuT14Hwj4io 39分钟前 7 10 已关闭

DOI:复制

文献链接:复制

其他信息:

S Cazzamalli, T Georgiev, F Migliorini, A Ciamarone…
2024
jnm.snmjournals.org
241120 Introduction: Lutetium Vipivotide Tetraxetan (Pluvicto TM, a Novartis product), a PSMA-targeted Radio Ligand Therapeutic (RLT), has revolutionized the treatment of metastatic castration-resistant prostate cancer. Despite the clinical benefit observed in large pivotal trials, virtually all patients treated with the drug eventually relapse (VISION trial). Moreover, the product shows an on-target off tumor uptake in healthy tissues, such as salivary glands and kidneys, which is responsible for certain toxicities observed in the clinic …

互助时间线

2026-09-22 17:24:11 [关闭求助]

系统关闭了求助

备注: 会议记录,无文献版本

2026-09-22 17:01:56 [发起求助]